Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Am J Prev Med. 2016 Apr 11;51(3):309–317. doi: 10.1016/j.amepre.2016.02.027

Figure 1.

Figure 1

Association between discounted QALYs gained and costs of vaccination.

Note: The crosses are when societal perspective is taken, and circles when healthcare perspective is taken. Regions below the dashed lines indicate cost-effective (<$159,123/QALY), whereas regions below the solid lines indicate very cost-effective (<$53,042/QALY). The different panels constitute different vaccination scenarios and vaccine effectiveness.

ICER, incremental cost-effectiveness ratio; LAIV, live attenuated influenza vaccine; IIV, inactivated influenza vaccine; QALY, quality-adjusted life years